Dr. Emil Kendziorra has a strong background in medicine, cancer research and entrepreneurship. He has been CEO of multiple tech and medical companies, most recently as a Founder and CEO of Medlanes, the leading digital house call provider in Germany. Before that he ran companies from digital agencies to data analysis companies.
Emil graduated summa cum laude in Medicine from University Medical Center Göttingen - one of the leading medical schools in Germany - with a doctoral degree in translational cancer research. He’s a regular keynote speaker on future of healthcare policy, the overlap of healthcare, science and technology as well as an advisor to insurances, hospital chains and pharmaceutical companies on digitalization topics.
Furthermore, he’s a mentor to a wide range startups as well as a crypto and early stage angel investor.

Patrick Burgermeister has a strong background in venture capital, pharma, banking and medtech. He is a Partner at the venture capital group BioMedPartners (Basel), a leading European investor in private life science companies. Before that, he was Senior Portfolio Manager at Novartis where he evaluated and prioritised all development projects from preclinical phase to registration.
Prior to Novartis, he was senior financial analyst responsible for the European Biotech and Pharma sector at Zürcher Kantonalbank. Patrick also headed the business development at the oncology company Apeiron Biologics (Vienna, Austria) and BioVersys (Basel). He successfully concluded several licensing deals and served on the board of many biotech and medtech companies.
Additionally, he is a board member of the business angel club BioBAC. Patrick holds a Master degree in Molecular Biology from the University of Basel (Biozentrum), a Master degree in Business Administration from the University of St. Gallen (HSG) and a degree as Chartered Financial Analyst (CFA).

Tayfun Ciçek began his career as an electrician in the canton of Zug. After successfully completing his apprenticeship and gaining his first professional experience, he completed the mandatory service in the Swiss Army. A professional reorientation brought him into the security sector. Among other things, he was responsible for monitoring sensitive installations. At the same time, he became interested in new medical developments. He is particularly interested in the sustainable treatment of terminal diseases. Tayfun Ciçek is currently working in the public sector in municipal administration and in his spare time, he is a member of the board of the association CryoSuisse.

Mathias Hirsch studied art history, archaeology and philosophy in Heidelberg and business administration at the University of Mannheim. In 1982 he completed his studies with the title Diplom Kaufmann. Since 1978 he has been managing the tour operator Hirsch Reisen in Karlsruhe as an authorized signatory and since 1982 as a managing partner. Hirsch Reisen is specialized in cultural tours in the broadest sense.
Since his early youth, Mathias Hirsch has been interested in prolonging people's lives in health. In autumn 2016, he and his friend Torsten Nahm founded the Hirsch Foundation, a charitable foundation, to support research in this field. Mathias Hirsch is convinced that a research institute in Switzerland has the best prerequisites to sustainably promote this process.

Nicolai Kilian has a strong background in business software development, identity & access management and website development. He is product owner, senior full-stack software developer and administrator in the IT identity services team of a big insurance company in Switzerland. Before that he was lead developer of an NLP software suite and webmaster in a Swiss IT company.
Nicolai holds a Diplom degree in Computational Linguistics - comprising computer science including machine learning, linguistics and mathematics - from Saarland University in Germany. He is also a certified Java developer, software architect, Scrum Master and Scrum Product Owner.

Torsten Nahm leads the Data Science Unit at DKB, a large German online bank. Before, he was Chief Risk Officer for a Berlin based startup, which he joined in 2015 and helped prepare for its IPO in 2018. He has also worked as a manager in several strategy and risk consultancies. Torsten studied mathematics, biology and medicine at the University of Bonn, and graduated with a Diploma in Mathematics in 2007.
Torsten has a deep and long experience in life extension and biostasis. He co-founded the German Society for Transhumanism in 1999, and the German Society of Applied Biostasis in 2006, serving on its board until 2014. He is convinced we are located at the cusp of a golden age of medicine, where science will make fundamental new contributions to health and longevity, and that we must seize and make the most of this chance.